Medizinische Universitaet Innsbruck

Neurology and Headache Disorders

Research activity includes migraine and restless leg syndrome, with interest in neurochemical and symptom-based outcomes linked to treatment response.

migraine
restless leg syndrome
cortical and thalamic neurochemistry
clinical symptom control

The sponsor’s neurology portfolio also extends to treatment-related changes in brain metabolism and movement-related sensory symptoms.

Psychiatry

Clinical research in schizophrenia focuses on cognitive functioning in patients undergoing adjustment of antipsychotic therapy.

schizophrenia
cognitive functioning
antipsychotic treatment

This area reflects interest in psychiatric symptom domains where cognition is a major therapeutic target.

Nephrology and Renal Disease

Work in kidney disease includes studies of minimal change disease and myeloma-related renal failure, with attention to renal recovery and disease control.

kidney disease
minimal change disease
renal recovery
myeloma-induced acute renal failure

These activities align with the functional expertise of the University Hospital for Internal Medicine IV in nephrology and hypertensiology.

Hematology and Oncology

Trials span multiple myeloma and non-small-cell lung cancer, including disease settings involving renal complications and surgically resectable solid tumors.

multiple myeloma
non-small-cell lung cancer
renal impairment in hematologic malignancy
neoadjuvant cancer therapy

The oncology portfolio also includes interest in immune-based and targeted treatment strategies across hematologic and solid tumor indications.

Hepatology, Cardiac Procedures, and Perioperative Care

Additional studies address alcohol-associated hepatitis and perioperative management for cardiac implantable electronic devices, with emphasis on patient comfort and recovery.